Magnetic resonance imaging in locally advanced rectal cancer : quantitative evaluation of the complete response to neoadjuvant therapy by Tarallo, Nicola et al.
e554 © Pol J Radiol 2018; 83: e554-e563
© Pol J Radiol 2018; 83: e554-e563
DOI: https://doi.org/10.5114/pjr.2018.81156
Received: 12.05.2018
Accepted: 13.09.2018
Published: 17.12.2018 http://www.polradiol.com
Original paper
Magnetic resonance imaging in locally advanced rectal cancer: 
quantitative evaluation of the complete response to neoadjuvant 
therapy
Nicola TaralloB,D,E,F, Maria Gloria AngerettiA,B,D, Elena BracchiA,B,D,E,F, Genti XhepaB,D,E, Valeria MolinelliA,B,F, 
Chiara TagliaferriD,E,F, Paolo AntognoniB,D,E, Raffaele NovarioC,D, Fausto SessaB,D, Carlo FugazzolaA,D,E,F
Università degli Studi dell’Insubria – Circolo Hospital and Macchi Foundation, Italy
Abstract
Purpose: To assess the diagnostic performance of diffusion-weighted imaging (DWI) for the discrimination of com-
plete responder (CR) from the non-complete responder (n-CR) in patients with locally advanced rectal cancer 
(LARC) undergoing chemotherapy and radiation (CRT).
Material and methods: Between December 2009 and January 2014, 32 patients (33 lesions: one patient had two syn-
chronous lesions) were enrolled in this retrospective study. All patients underwent a pre- and post-CRT conventional 
MRI study completed with DWI. For both data sets (T2-weighted and DWI), the pre- and post-CRT tumour volume 
(VT2; VDWI) and the tumour volume reduction ratio (∆V%) were determined as well as pre- and post-CRT apparent 
diffusion coefficient (ADC) and ADC change (∆ADC%). Histopathological findings were the standard of reference. 
Receiver operating characteristic (ROC) curves were generated to compare performance of T2-weighted and DWI 
volumetry, as well as ADC.
Results: The area under the ROC curve (AUC) revealed a good accuracy of pre- and post-CRT values of VT2 (0.86; 0.91) 
and VDWI (0.82; 1.00) as well as those of ΔVT2% (0.84) and ΔVDWI% (1.00) for the CR assessment, with no statistical 
difference. The AUC of pre- and post-CRT ADC (0.53; 0.54) and that of ΔADC% (0.58) were significantly lower.
Conclusions: Both post-CRT VDWI and ΔVDWI% (AUC = 1) are very accurate for the assessment of the CR, in spite of 
no significant differences in comparison to the conventional post-CRT VT2 (AUC = 0.91) and ΔVT2% (AUC = 0.84). 
On the contrary, both ADC and ΔADC% values are not reliable.
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Introduction
Locally advanced rectal cancer (LARC) – defined by the 
parameters cT3-T4, N –/+, and M0 – has a five-year sur-
vival rate equal to 50-65%, with a local recurrence rate of 
30-40% and a high incidence of metastasis [1,2]. Over the 
past 20 years, the “total mesorectal excision” (TME) has 
fostered a considerable reduction of recurrence of LARC; 
nevertheless, it has significant post-surgical complications 
(anorectal, urinary, and sexual dysfunction), and post- 
operative mortality is still relevant (range: 2-30% within 
six months of surgery) [3,4].
Currently the treatment of LARC is oriented towards 
the use of neoadjuvant therapies, radiotherapy combined 
with chemotherapy (CRT), which further reduces the re-
currence rate, leading to volume reduction and tumour 
downstaging [4]. In patients affected by LARC, a complete 
histopathological response after CRT occurs in 10-30% of 
cases at the time of surgery and is related with better prog-
nosis in terms of local recurrence as well as disease-free 
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and overall survival; it has also been demonstrated that 
neoadjuvant therapy alone, in an accurately selected 
group of patients, represents a safe treatment associated 
with a good survival rate at five years (overall surviv-
al 88% and disease-free 83%) [2,4-7]. A “wait and see” 
approach has been proposed for patients with complete 
clinical response after CRT. For this reason, it is necessary 
to identify imaging methods capable of discriminating 
“complete responder” patients (CR) from “non-complete 
responder” patients (n-CR) [2,5-7].
Magnetic resonance imaging (MRI) is the best imag-
ing technique for the evaluation of tumour response to 
CRT [8,9]. However, the conventional MR sequences are 
not sufficiently reliable in distinguishing between residual 
tumour and fibrotic reaction after chemoradiation [1,8,9].
The current guidelines of the European Society of 
Gastrointestinal and Abdominal Radiology (ESGAR) sug-
gest the use of diffusion-weighted MR imaging (DWI) in 
post-CRT restaging [8] because there is growing evidence 
that the qualitative analysis of DWI sequences improves 
the diagnostic performance in the evaluation of the re-
sponse (stage-yT) to neoadjuvant CRT [4,8-10]. Diffu-
sion-weighted MRI is a functional imaging technique 
that analyses differences in the extracellular movement 
of water protons to discriminate between tissues of var-
ying cellularity, with a potentially beneficial role for the 
detection and characterisation of malignant tumours; it 
can provide a quantitative assessment by measuring the 
apparent diffusion coefficient (ADC) [5,11-21]. In order 
to identify CR patients, a few studies have performed 
quantitative assessments by calculating pre- and post-CRT 
mean ADC values of the tumour [12,15-17,22], as well as 
the percentage of ADC change (ΔADC%) [12,15,17], with 
contradictory results.
Other studies, by calculating the tumour volume on 
conventional MR sequences (VT2) pre- and post-CRT and 
the volume reduction rate (ΔVT2%) [23-26], have also ob-
tained conflicting results. Therefore, in order to distin-
guish CR from n-CR, other authors have proposed the 
evaluation of the functional volumetry (VDWI) performed 
on pre- and post-CRT DW images on high b-value and 
the volume reduction rate (ΔVDWI%) [5,14,27].
The aim of our study was to assess the diagnostic per-
formance of DWI by calculating the VDWI (compared to 
VT2), the ADC values, and the relative Δ% for the discrim-
ination of CR from the non-CR after CRT.
Material and methods
Fifty patients with MRI diagnosis of LARC between Decem-
ber 2009 and January 2014 were considered for inclusion in 
our retrospective study based on the following criteria:
• endoscopic diagnosis and histopathologically (biopsy) 
proven rectal carcinoma;
• conventional MR pre-CRT completed with DWI 
which confirmed the tumour and allowed accurate 
locoregional staging (all tumours were T3 – locally 
advanced – regardless of the distance from the me-
sorectal fascia);
• combined neoadjuvant therapy: the treatment pro-
tocol included external beam radiotherapy for a total 
of 45 to 50.4 Gy (1.8 Gy/fraction) and chemotherapy 
with 5-fluorouracil (continuous infusion of 225/mg/
m2/day for seven days for the duration of radiation 
therapy) or Capecitabine per os (825 mg/m2 two times 
per day, from Monday to Friday, for the duration of 
the radiation treatment);
• conventional MR completed with DWI after neoadju-
vant treatment; 
• histopathological examination of the surgical spec-
imen or, alternatively, biopsy performed during fol-
low-up endoscopy in patients with strong evidence of 
complete response to therapy based on clinical and 
instrumental investigations, in which an attitude of 
surveillance was considered preferable to surgical ap-
proach.
Of the 50 patients initially enrolled, 18 were exclud-
ed for the following reasons: two patients for metastatic 
disease and comorbidities; one patient for poor quality 
of DWI due to artefacts caused by metallic hip implants; 
four patients lost at follow-up (FU) after performing post-
CRT MR; and 11 patients underwent surgery after staging 
MRI. The final population eligible for our study encom-
passed 32 patients (33 lesions in 32 patients: one patient 
had two synchronous lesions, one in the rectum and one 
in the anal canal): 18 males and 14 females – mean age 
65.9-years (range: 35-85 years).
All MR images were retrospectively evaluated in con-
sensus by two radiologists (GA; EB); the observers were 
blinded to the clinical patient data and pathology reports.
Standard of reference
Twenty-nine of 32 patients underwent TME; 3/32 patients 
did not undergo surgery, due to strong clinical evidence of 
a complete response (repeated negative colonoscopy and 
biopsies after CRT). 
Tumour response after CRT was determined in all 
the 33 lesions according to the pathological classification 
suggested by Dworak’s tumour response grading system 
[14,28] (TRG): grade 4, no tumour cells, only a fibrotic 
mass (CR); grade 3, very few tumour cells in fibrotic tis-
sue with or without mucous substance (near CR); grade 2, 
dominantly fibrotic changes with few minor cells or 
groups (moderate response); grade 1, dominant tumour 
mass with obvious fibrosis and/or vasculopathy (minimal 
response); grade 0, no regression.
MRI technique
All patients provided written, informed consent and were 
investigated by MRI with a magnetic field of 1.5 Tesla 
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(Magnetom Avanto, Siemens Medical Solutions, Erlangen, 
Germany; Philips Achieva, Best, Nederland). Patients did 
not receive bowel preparation; however, in 57/64 MR ex-
aminations rectal distension was performed with 50-120 cc 
of ultrasound gel; in 7/64 examinations no rectal disten-
sion was performed due to lack of cooperation of the pa-
tients (4/7cases) or to low rectal tumours (the lesion was 
in the lumen of the anal canal in 3/7 cases).
All patients were placed in the supine position, and 
a phased-array body coil was used. The imaging protocol 
consisted of the following:
• sagittal TSE T2-weighted (TR: 3200 ms; TE: 100 ms; 
FOV 280 × 280; matrix 348 × 280; two signal averages; 
slice thickness: 3 mm);
• paraxial (section perpendicular to the longitudinal 
tumour axis) TSE T2-weighted to accurately evaluate 
the tumour thickness (TR 3000 ms; TE 100 ms; matrix 
348 × 278; three signal averages; FOV 210 × 228 mm; 
slice thickness: 3 mm);
• para coronal (section parallel to the longitudinal 
tumour axis) TSE T2-weighted (TR: 3.200 ms; TE: 
100 ms; matrix 348 × 280; two signal averages; FOV 
280 × 280 mm; slice thickness: 3 mm);
• paraxial DWI (TR: 5.400 ms; TE: 53 ms; matrix: 250 
× 200; four signal averages; FOV: 350 × 306 mm; slice 
thickness: 4 mm; using two b-value: 0, 800 s/mm2) 
[5,8,25].
T2-weighted and DWI volumetric evaluation
On the T2-weighted images, tumours were defined as ar-
eas of intermediate signal compared with the hypointense 
signal of the normal adjacent muscular rectal wall (Fig-
ure 1A). On post-CRT T2-weighted MR images, areas of 
markedly low signal intensity (SI) at the location of the 
primary tumour bed were interpreted as fibrosis. As the 
risk for residual tumour in these fibrotic areas is known to 
be about 50% [5,6,14,27], they were also included in the 
volumetric measurements (Figure 1D).
On the pre- and post-CRT DW images, measurements 
were performed on high b-value (800 s/mm2) images (Fig-
ure 1B, E). During the DWI analysis session, T2-weighted 
images were used as the reference for tumour location. 
On DW images, tumours were identified as areas of high 
SI; on the post-CRT acquisition, complete response was 
defined as complete absence of SI in the previous tu-
mour site, using normal rectal wall as internal reference 
[4,5,14,27] (Figure 1E).
Volumetric assessment of the tumour was performed 
for each lesion, in both paraxial sections on T2-weighted 
and DW images on high b-value (b = 800 s/mm2) with 
identical angled planes. Freehand regions of interest 
(ROI) were manually drawn at the edges of the tumour for 
each section containing the lesion. Whole tumour volume 
was calculated by multiplying each cross-sectional area 
by the section thickness and then summing all the partial 
volumes [5,27,29] (Figure 1A, B, D, E).
For both data sets (T2 weighted and DWI), the pre- 
and post-CRT tumour volumes (VT2 and VDWI) were deter-
mined; moreover, the tumour volume reduction ratios for 
both T2-weighted and DW images (ΔVT2% and ΔVDWI%) 
were calculated as follows: (Vpre – Vpost )/Vpre × 100 
[5,14,27].
Measurement of the ADC
ADC maps were automatically generated by using a mo-
noexponential decay model including the two b values 
(0 and 800 s/mm2), on which freehand ROIs were drawn 
at the edges of the tumour for each axial section contain-
ing the lesion [5,29] (Figure 1C).
The tumour margins on ADC maps were defined re-
ferring to the paraxial T2-weighted and DW images on 
the high b value (b = 800 s/mm2); mean ADC value was 
extrapolated by ADC values obtained in the axial sections 
and the relative standard deviations with the goal of re-
ducing the structural differences induced by the inherent 
tumour heterogeneity. 
When no remaining high SI was visualised on the 
post-CRT DW images (Figure 1E), three ROIs were drawn 
at the former location of the primary tumour with refer-
ence to the post-CRT paraxial T2-weighted images [5,29] 
(Figure 1F).
Mean ADC values of the tumour lesions (pre- and 
post-CRT) as well as the percentage of ADC change 
(ΔADC%) were calculated. ΔADC% was determined as 
follows: (ADCpost – ADCpre)/ADCpre × 100 [15].
Statistical analysis
The following statistical analyses were performed by using 
GraphPad software (MedCalc Software, version 5.02):
• the Wilcoxon test was used to compare pre- vs. post-
CRT VT2, VDWI, and mean ADC values of the 33 le-
sions included in the study;
• the Mann-Whitney test was used to compare pre- vs. 
post-CRT VT2, VDWI, mean ADC values, and relative 
ratio (ΔVT2%; ΔVDWI% ; ΔADC%) for CR vs. n-CR; 
• receiver operating characteristic (ROC) curves were 
generated and applied to the above values to assess 
the diagnostic performance in detecting a CR; cor-
responding area under the ROC curve (AUC) was 
considered for the determination of diagnostic accu-
racy and a 95% confidence interval (CI) expressed 
the statistical precision of the results. For these anal-
yses, cut-off values were determined according to 
the point nearest to the upper left corner in the ROC 
curves. The interpretation of the AUC values refers to 
the classification proposed by Swets [30]. A difference 
with a P value < 0.05 was considered significant.
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Figure 1. 61-year-old woman with distal rectal advanced adenocarcinoma: CR post-CRT. A) Pre-CRT T2-weighted axial image shows the mass; freehand ROI 
was drawn along the border of the lesion for calculation of the sectional area of tumour; sectional area was multiplied by section thickness to determine 
the tumour volume (VT2 = 6.8 cm
3). B) Pre-CRT DW axial image (b value: 800 s/mm2): a freehand ROI was drawn for the calculation of the sectional area of 
tumour and of the tumour volume (VDWI = 1.97 cm
3). C) Pre-CRT axial ADC map: a freehand ROI was drawn for the calculation of the ADC; the mean ADC value 
was calculated from the different axial values (1.23 ± 0.26 × 10–3 mm2/s). D) Post-CRT T2-weighted axial image shows slight rectal wall thickening with 
hypointense signal, interpreted as fibrosis; freehand ROI was drawn along the border of the thickening; sectional area was multiplied by section thickness 
to determine the tumour volume (VT2 = 0.94 cm
3) and the tumour reduction ratio (∆VT2% = 86.2%). E) Post-CRT DW axial image (b value: 800 s/mm
2): 
no residual hyperintense signal is observed in the corresponding lesion, therefore tumour volume (VDWI) is equal to 0 cm
3 and ∆VDWI% to 100%. F) Post-CRT 
axial ADC map: freehand ROI is drawn along former location of the tumour demonstrated by the T2 weighted image, for the calculation of the ADC (mean 
value: 1.73 ± 0.19 × 10–3 mm2/s) and ADC change (∆ADC% = 41%). A correct prediction of the complete tumour response was made by post-CRT VT2 and 
VDWI, as well as by ∆VDWI%. Pathological examination of resected specimen revealed no residual tumour cells (TRG 4)
Results
Fourteen of the 32 patients included in our study under-
went anterior resection of the rectum and 15/32 under-
went abdominoperineal resection. Three patients were 
monitored with endoscopy and concomitant biopsy (neg-
ative results for the presence of residual disease) and un-
derwent FU with MRI investigation every 3-6 months for 
the first year and then annually (mean FU: 5 years and 
three months). 
The mean time between the end of neoadjuvant thera-
py and restaging MR imaging was 53.4 days (range: 38-82 
days), and the mean time between the post-CRT MR im-
aging and surgery (or biopsy) was 21.2 days (range: 2-60 
days).
Pathologic examination revealed 32/33 rectal ade-
nocarcinoma and 1/33 mucinous type adenocarcinoma 
(32 patients, one with a double synchronous lesion). The 
locations of the tumours were: four proximal rectum, 
17 middle rectum, eight distal rectum, and four anal canal. 
The histopathological examination provided the following 
results: 4/33 lesions were considered G0, 13/33 as G1, 7/33 
as G2, 2/33 as G3, and 7/33 as G4 (4/7 with histopatholog-
ical examination of the surgical specimen and 3/7 evalu-
ated on the biopsy material); the CR group was therefore 
composed of 7/33 patients and the n-CR group of 26/33 
patients. In relation to the (yT) staging: 7/33 lesions were 
yT0 (including 4ypT0); 2/33: ypT1; 9/33: ypT2; 12/33: 
ypT3; 3/33: ypT4.
Conventional T2-weighted volumetry vs. DWI volumetry
A statistically significant (p < 0.0001) reduction of median 
tumour volume of both VT2 and VDWI pre- vs. post-CRT 
was noted for all 33 lesions included in the study, respec-
tively, from 26.4 cm3 to 11.4 cm3 and from 14.8 cm3 to 
5.3 cm3 (Table 1).
The pre- and post-CRT median tumour volumes in 
the CR group were significantly lower compared to the 
n-CR group, both on T2-weighted images (VT2 pre-CRT: 
16.1 cm3 vs. 29.97 cm3, p = 0.0037; VT2 post-CRT: 1.3 cm3 
vs. 14.3 cm3, p = 0.001) and on DWI (VDWI pre-CRT: 
6.6 cm3 vs. 17.99 cm3, p = 0.008; VDWI post-CRT: 0.00 cm3 
vs. 8.7 cm3, p = 0.0001) (Table 1). The ΔV% was signifi-
cantly higher in the CR group compared to n-CR group, 
both in T2-weighted images (ΔVT2%: 84.9% vs. 50.7%, 
p = 0.005) and in DWI (ΔVDWI%: 100% vs. 43.7%, 
p = 0.0001) (Table 1).
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Table 1. Median volumes and ADC values (33 tumours)
Measurements Lesions (n = 33) CR (n = 7) n-CR (n = 26) p value
VT2
pre-CRT (cm3) 26.4 (2.2-101.6) 16.1 (2.2-24.9) 29.97 (8.5-101.6) 0.0037
post-CRT (cm3) 11.4 (0.6-93.9) 1.3 (0.6-11.4) 14.3 (1.3-93.9) 0.001
ΔVT2% 49.5 (1.5-94.9) 84.9 (49.5-94.9) 50.7 (1.5-88.6) 0.005
VDWI
pre-CRT (cm3) 14.84 (1.97-101.3) 6.6 (1.97-17.5) 17.99 (3.7-101.3) 0.0082
post-CRT (cm3) 5.3 (0-92.9) 0.00 (0-0.5) 8.7 (1.16-92.9) 0.0001
ΔVDWI % 55.3 (2-100) 100 (94.2-100) 43.7 (2-83) 0.0001
ADC
pre-CRT (× 10ˉ³ mm²/s) 1.11 (0.74-1.9) 1.11 (0.89-1.23) 1.11 (0.74-1.9) 0.8
post-CRT (× 10ˉ³ mm²/s) 1.47 (1.1-2.1) 1.42 (1.2-1.7) 1.51 (1.1-2.1) 0.7
ΔADC% 24.5 (0.8-95) 28 (23-41) 22 (0.8-95) 0.4
Median ADC value
For the 33 lesions included in the study a significant in-
crease in median ADC value post- vs. pre-CRT (1.47 
± 0.27 × 10-3 mm2/s vs. 1.11 ± 0.29 × 10-3 mm2/s, 
p = 0.0001), expressed by the value ΔADC% (24.5%), was 
found. 
Nevertheless, no statistically significant differ-
ence was found between median ADC values pre-CRT 
(p = 0.8), post-CRT (p = 0.7), and ΔADC% (p = 0.4) in the 
CR group compared to the n-CR group (Table 1).
Diagnostic performance to identify complete responder
The ROC curves were used to compare the diagnostic per-
formances of VT2 and ΔVT2%, of VDWI and ΔVDWI%, as well 
as the ADC values and the ΔADC% (Table 2, Figure 2). 
The AUC for the above values pre/post-CRT was, re-
spectively, 0.86/0.91 for VT2, 0.82/1.00 for the VDWI and 
0.53/0.54 for ADC. A significantly greater accuracy was 
documented for VT2 and VDWI vs. the ADC values, pre- 
and post-CRT; nevertheless, there were no significant 
differences in AUC among VT2 and VDWI (Table 2, Figure 
2A, B).
The results for AUC of ΔVT2% (0.84) and ΔVDWI% 
(1.00) were significantly better than AUC of ΔADC% 
(0.58) (Table 2, Figure 2C), without statistically significant 
differences between the ΔVT2% and ΔVDWI%. 
In the absence of significant differences between VT2 
and VDWI (pre- and post-CRT) and ΔV%, the more accu-
rate parameters for the assessment of CR (AUC = 1) were 
represented by the VDWI post-CRT and ΔVDWI%. 
Comparison between qualitative and volumetric 
evaluation of DWI
We correctly identified as CR 6/7 lesions on the basis of 
the absence of SI on DWI on high b-value. One false neg-
Table 2. Diagnostic performance of volume measurements from T2-weighted and DW MR images and ADC in detection of a CR (33 tumours)
Measurements AUC Optimal cut-off Sensitivity Specificity
pre-CRT
VT2 0.86 24.87 cm
3 100 (7/7) 73 (19/26)
VDWI 0.82 11.04 cm
3 86 (6/7) 73 (19/26)
ADC 0.53  1.23 × 10ˉ³ mm2/s 100 (7/7) 31 (8/26)
post-CRT
VT2 0.91 2.43 cm
3 71 (5/7) 96 (25/26)
VDWI 1.00 0.5 cm
3 100 (7/7) 100 (26/26)
ADC 0.54  1.5 × 10ˉ³ mm2/s 71 (5/7) 58 (15/26)
Δ%
ΔVT2 0.84 65.3% 86 (6/7) 77 (20/26)
ΔVDWI 1.00 83% 100 (7/7) 100 (26/26)
ΔADC 0.58 22% 100 (7/7) 54 (14/26)
 MR imaging in locally advanced rectal cancer
e559© Pol J Radiol 2018; 83: e554-e563
Figure 2. A) Comparison of the areas under the ROC curves (AUCs) applied 
to the VT2, VDWI and ADC pre-CRT revealed the absence of a significant differ-
ence between the VT2 (0.86) and VDWI (0.82), both with significant difference 
compared with the ADC (0.53). B) Comparison of AUCs post-CRT equally 
revealed the absence of a significant difference between the VT2 (0.91) and 
VDWI (1.00), both with significant difference compared with the ADC (0.54). 
C) Comparison of AUCs applied to the respective percentage ratios (∆VT2%, 
∆VDWI% and ∆ADC%) revealed absence of a significant difference between 
the ∆VT2% (0.84) and ∆VDWI% (1.00), both with significant difference com-
pared with ∆ADC% (0.58). VDWI post-CRT and the ∆VDWI% were the most 
accurate parameters in recognising the CR (AUC = 1)
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ative (FN) was documented: on the post-CRT DW images 
a focal area of high SI at the location of primary tumour 
was misinterpreted as residual tumour (time between 
post-CRT MR and surgery: 35 days); histopathological 
examination revealed the complete absence of malignant 
epithelial cells in the presence of diffuse fibrosis enclosing 
mucin pools (Figure 3). 
The VDWI post-CRT and ΔVDWI% of FN were, respective-
ly, 0.5 cm3 and 94.2%; these values hang outward the range 
of VDWI post-CRT and ΔVDWI% of n-CR patients (Table 1); 
moreover, no overlap was found in comparison to the 2/33 
lesions of the G3 group (VDWI post: 5.28-21.69 cm3; ΔVDWI%: 
32.5-41.7%).
Discussion
Identifying MR predictive biomarkers or indicators of 
tumour response to neoadjuvant CRT in patients with 
LARC is still a challenge. Conventional MR sequences 
are not sufficiently reliable in distinguishing between re-
sidual tumour and post-CRT tissue fibrosis [1,8,9]. How-
ever, it has been shown that the qualitative assessment 
of DWI sequences significantly improves the diagnostic 
performance of conventional MRI in the evaluation of 
tumour response to CRT, as regards both the downstag-
ing (T stage) [4] and the tumour response grading (TRG) 
[6,8,10,31]; particularly, in distinguishing between CR 
and n-CR patients, DWI has shown a higher sensitivity 
(52-64% vs. 0-40%) and an almost comparable specificity 
(89-97% vs. 92-98%) vs. standard MR sequences [10].
However, DW images have limitations because com-
plete tumour regression is not always accompanied by the 
absence of SI due to the fact that diffuse fibrosis associated 
with chronic inflammation, the presence of mucin pools, 
the air-rectal wall interface, or the collapsed rectal wall 
may be visualised as high SI, making the identification of 
CR difficult [5,10,14]. This also occurred in 1/7 CR pa-
tients of our series (Figure 3).
Therefore, the MR quantitative evaluations have been 
proposed by calculating the mean ADC values [13,15-17], 
the conventional volumetry on T2-weighted images (VT2) 
[23,24] and, more recently, the volume measured on the 
DW images (VDWI) [5,14,27], as well as the ratio between 
the values before and after CRT (Δ%) [5,12,14-17,23-25,27].
Promising results have been reported regarding the 
calculation of the ADC to assess the response to neo-
adjuvant treatment in patients with complete response 
(TRG 4 or ypT0) as well as near-complete response (TRG 
3-4 or ypT0-T2) [12-15,17,18]. When considering only 
studies that compared groups of patients n-CR vs. CR in 
relation to the TRG (G4 vs. G0-G3), some studies claim 
that the pre-CRT ADC values in tumours of CR patients 
were significantly lower than those of n-CR [12], while 
the post-CRT ADC values [15,22] and those of ΔADC% 
[12,15,17] were significantly higher. In fact, high cellular-
ity corresponds to a good tumour response, and therefore 
low ADC values pre-treatment indicate the CR patients 
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Figure 3. 53-year-old man with middle rectal advanced adenocarcinoma CR post-CRT. A) Pre-CRT T2-weighted axial image shows the tumoural mass 
bounded by freehand ROI (VT2 = 9.9 cm
3). B) Pre-CRT DW axial image (b value: 800 s/mm2) shows an hyperintense signal in the tumoural area bounded 
by the freehand ROI (VDWI = 8.6 cm
3). C) Post-CRT T2-weighted axial MR image shows rectal wall thickening with an area of intermediate SI interpreted as 
residual tumour, bounded by the freehand ROI (VT2 = 0.9 cm
3). D) Post-CRT axial DWI shows a linear hyperintense signal, interpreted as residual tumour at 
qualitative evaluation, bounded by the ROI (VDWI = 0.5 cm
3). Although both T2-weighted and DW images wrongly demonstrate a residual tumour, a correct 
prediction of the complete tumour response is made by post-CRT VT2 and VDWI as well as by ∆VT2% (94%) and ∆VDWI% (94.2%). Pathologic examination of 
resected specimen revealed no residual tumour cells (TRG 4)
[18]. However, there are aggressive tumours, character-
ised by predominantly coagulative necrosis, and thus with 
low ADC values, which may not respond favourably to 
neoadjuvant CRT [18]. This justifies the low ADC values 
pre-CRT also detected in the n-CR of our series; the bi-
ological aggressiveness of these tumours is confirmed by 
the tendency to infiltrate the mesorectal fascia and the 
lymph node involvement [21].
Some studies sustain that post-CRT ADC might not 
be able to highlight microscopic residual tumour in are-
as of fibrosis and/or post-actinic necrosis and therefore 
does not allow reliable discrimination of CR patients from 
“near-CR” patients [6,15,16]. In our series, considering 
the entire group of lesions (CR + n-CR), the post-CRT 
ADC value, while being significantly higher than the pre-
CRT ADC value, was not able to distinguish CR patients 
from n-CR; moreover, the ΔADC% was not able to make 
such a discrimination. Similar conclusions on the limit-
ed usefulness of the various measurements of the ADC 
– including the ΔADC% – for the assessment of CR also 
emerged from other studies [4,5,14].
Based on our experience and the literature, we believe 
that the conflicting results in the evaluation of the ADC 
can be related to the small number of patients with com-
plete remission included in the different studies (range: 
9-35 CR from a total of 30-100 CR + n-CR) [5,14-17], 
and to the variability of the technique employed for the 
measurements [32]. 
Concerning the volumetric evaluation with MR 
T2-weighted imaging, some studies associate the ability 
to identify the CR with a volume reduction rate (ΔVT2%) 
> 73.6-86.6% [12,14,24-27]; in particular Curvo-Semedo 
 MR imaging in locally advanced rectal cancer
e561© Pol J Radiol 2018; 83: e554-e563
et al. [5] reported an AUC = 0.84 and Ha et al. [14] an 
AUC = 0.792. However, as regards the post-CRT VT2, con-
flicting results have been reported: Ha et al. [14] found an 
AUC = 0.705; on the other hand, Kang et al. did not asso-
ciate the post-CRT VT2 with the ability to identify the CR 
[24]. Curvo-Semedo et al. also considered the post-CRT 
VT2 significant, although less accurate (AUC = 0.70) than 
ΔVT2%; moreover, they did not consider the pre-CRT VT2 to 
be significant (AUC = 0.57) [5]. Lambregts et al. confirmed 
the results of the above-mentioned studies [5,14], report-
ing a good accuracy for both ΔVT2% (AUC = 0.78) and 
post-CRT VT2 (AUC = 0.82) as well as for the pre-CRT VT2 
(AUC = 0.73) [27]. Finally, other studies did not find any 
significant difference in order to identify the CR (TRG 4) as 
well as the “good responders” (TRG 3-4), arguing that the 
pre- and post-CRT volumes measured on T2 and the re-
spective reduction ratio could not be used for the selection 
of appropriate treatment options because these two param-
eters were not sufficiently reliable in distinguishing between 
residual tumour and post-CRT tissue fibrosis [23,33].
Three studies, published between 2011 and 2015, 
which ascribed low usefulness to the measures of the 
ADC in distinguishing CR patients from n-CR (as men-
tioned above), argued that the tumour volume measured 
in the DW images was more accurate than that obtained 
in the conventional T2 MR sequences. In particular, 
Curvo-Semedo et al. [5] assign the best performance to 
post-CRT VDWI (AUC = 0.93), which is significantly more 
accurate than post-CRT VT2 (AUC = 0.70) and compara-
ble in accuracy to ΔV% in both DWI (AUC = 0.92) and 
T2-weighted images (AUC = 0.84); conversely, the pre-
CRT VDWI as well as pre-CRT VT2 are not accurate. These 
findings suggest that the evaluation of post-CRT DWI can 
be sufficient, so pre-CRT images do not necessarily have 
to be assessed. Ha et al. recognised ΔVDWI% as having the 
best performance (AUC = 0.91) in order to identify the 
CR; this value is significantly more accurate than ΔVT2% 
(AUC = 0.792), as well as post-CRT ADC (AUC = 0.705). 
They also reported a significant difference between CR pa-
tients and n-CR with regard to the median value of post-
CRT VDWI, calculated by Wilcoxon test (p < 0.01) [14]. 
Recently, Lambregts et al. [27], by using the same cut-off 
values proposed by Curvo Semedo et al. [5], confirmed 
the previous results in a bi-institutional study and pointed 
out that the post-CRT VDWI (AUC = 0.92) has the best 
diagnostic performance.
The results of our series reveal good accuracy of post-
CRT VT2 (AUC = 0.91) and ΔVT2% (AUC = 0.84) (Table 2, 
Figure 2); post-CRT VDWI and ΔVDWI% results were more 
accurate (AUC = 1) compared to the corresponding post-
CRT VT2 and ΔVT2%; however, the differences were not 
statistically significant. Moreover, our values of optimal 
cut-off are different from those reported in the other pub-
lished studies [5,14,27]. Furthermore, it has to be empha-
sised that even our pre-CRT VDWI (AUC = 0.82) as well as 
pre-CRT VT2 (AUC = 0.86) were accurate in identifying 
the CR; these latter findings, in disagreement with the 
literature [5,14,27], show a limitation of our study, repre-
sented by the small size of the pre-CRT lesions with com-
plete histopathological response.
Finally, all the tumour volumes measured on the DW 
images, as in other studies [5,14,27], were smaller than those 
on the T2-weighted images; on DW imaging ROIs were 
drawn delimiting the areas of high SI, while in T2-weight-
ed images areas of fibrosis were also included within the 
ROIs because the risk of residual tumour in the fibrotic ar-
eas is known to be about 50% [5,6,14,27]. Therefore, our 
experience confirms that volumetry on DW images is more 
accurate than that on T2-weighted images: in particular, 
post-CRT VDWI ≤ 0.5 cm3 and ΔVDWI% ≥ 83% (our values 
of optimal cut-off) could indicate a pathological complete 
response. However, it still remains difficult to differenti-
ate between patients with a CR (TRG 4) and patients with 
small microscopic clusters of residual neoplasm (TRG 3) 
[5]; further studies are required to address this issue.
Nevertheless, at present, although the tumour volumes 
determined on the basis of the presence (or absence) of 
high-signal intensity areas on DW-MRI better represent 
the existence of residual viable tumour, we can hypoth-
esise – in agreement with Curvo-Semedo [34] – that 
a visual evaluation of a high-signal intensity area sugges-
tive of residual tumour is sufficient, and volumetric meas-
urements are not even required. Such a visual approach 
would also be more practical and far less time consum-
ing [34] because of the manual measurement of tumour 
volume; the use of a (semi-)automated segmentation ap-
proach is a potentially time-saving alternative, as demon-
strated by a recent study [35]. Hence, the combined T2 
morphology and qualitative/volumetric DWI evaluation 
can form the cornerstone of clinically applicable daily rec-
tal MRI interpretation [36]. Moreover, the combination of 
MRI with clinical assessment (digital rectal examination 
and endoscopy) is recommended as the optional strategy 
for safe and accurate selection of CRs after CRT [37].
There were some limitations to our study: the small 
number of selected patients (especially the small sample 
of CR); the small size of the pre-CRT lesions with patho-
logical complete response; histopathological evaluation of 
tumour regression to therapy was performed on biopsy 
in 3/7 CR; the lack of direct correlation between volu-
metric data obtained by MR images and the volumetric 
data provided by the surgical specimens; the possible er-
rors in the positioning and size of the ROIs drawn on the 
tumour margins, not easily identifiable especially in the 
examinations performed after CRT, due to the low spatial 
resolution and low signal/noise ratio in the DW images 
and ADC maps; the inter-observer reproducibility of the 
method was not evaluated because of the long time re-
quired for measurements of volumes and ADC values; 
and finally, post-CRT N parameter, so far considered in 
a single study [4], was not assessed. However, the prev-
alence of a positive lymph node status in the case of CR 
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of the primary tumour after CRT is very low (8%) [10]; 
moreover, standard MRI is quite accurate in lymph node 
staging after CRT, so the addition of functional imaging, 
such as DWI, may not even be necessary [38].
In conclusion, DW images improve the results of 
standard follow-up MR protocols in order to identify 
CR patients after neoadjuvant CRT in patients affected 
by LARC. The functional volumetry is better than the 
conventional volume, although no statistically signifi-
cant differences were detected in this study. In particular, 
both post-CRT VDWI and ΔVDWI% results are very accu-
rate; however, standardised cut-off values are not availa-
ble. Conversely, the pre- and post-CRT ADC values and 
ΔADC% are not sufficiently reliable to distinguish the CR 
patients from the total group of n-CR patients.
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